Levetiracetam Altan (Levetiracetam)

Levetiracetam binds to the synaptic vesicle protein SV2A, which modulates neurotransmitter release and stabilizes neuronal membranes. This reduces abnormal neuronal firing and lowers the likelihood of seizure activity across various seizure types.

The appropriate dose of Levetiracetam Altan is determined by the prescribing clinician based on the patient’s clinical condition, weight, renal function, and therapeutic response. Dosing regimens are individualized and should follow the prescriber’s instructions.

Levetiracetam is classified as pregnancy category B, indicating that animal studies have not shown risk but there are no adequate human studies. It should be used during pregnancy only if the potential benefit justifies the potential risk. Limited data are available for breastfeeding, so clinical judgment is required.

To order Levetiracetam Altan, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Levetiracetam offers a distinct mechanism by targeting SV2A, which differs from many antiepileptics that act on ion channels or G‑protein pathways. It has a relatively favorable drug‑interaction profile and does not require routine therapeutic drug monitoring, making it a convenient option compared with agents such as carbamazepine or phenytoin.

Levetiracetam Altan should be stored at ambient temperature, protected from moisture and direct light, and kept in its original packaging until use. Do not freeze the solution and ensure the container remains sealed to maintain sterility.

Levetiracetam Altan is supplied as an intravenous solution and is administered directly into a vein by a qualified healthcare professional. The infusion rate and volume are determined by the prescriber based on the patient’s clinical needs.

Serious risks include severe allergic reactions (such as anaphylaxis), significant mood or behavioral changes (including depression, suicidal thoughts, or aggression), and hematologic abnormalities like thrombocytopenia or leukopenia. Prompt medical attention is required if any of these events occur.

Levetiracetam Altan is contraindicated in patients with known hypersensitivity to levetiracetam or any component of the formulation. Caution is advised for individuals with severe renal impairment, uncontrolled psychiatric disorders, or those taking medications that may markedly reduce its plasma concentration.